Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis Inc
(NQ:
PSNL
)
2.980
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 01, 2022
Via
Benzinga
Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer
November 30, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference
November 21, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis's Return On Capital Employed Overview
November 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Expert Ratings for Personalis
May 05, 2022
Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
November 07, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Third Quarter 2022 Financial Results
November 02, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business
October 31, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter 2022 Financial Results
October 19, 2022
From
Personalis, Inc.
Via
Business Wire
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer
October 04, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
August 30, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics
August 17, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers
August 15, 2022
From
Personalis, Inc.
Via
Business Wire
5 Top Stocks Cathie Wood Bought This Week
August 05, 2022
Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week.
Via
InvestorPlace
Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
August 04, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis: Q2 Earnings Insights
August 03, 2022
Personalis (NASDAQ:PSNL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Personalis beat estimated...
Via
Benzinga
Personalis Reports Second Quarter 2022 Financial Results
August 03, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics
August 02, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Second Quarter 2022 Financial Results
July 20, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease
July 12, 2022
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
During the Thursday's session, 100 stocks hit new 52-week lows.
Via
Benzinga
Personalis Reports First Quarter 2022 Financial Results
May 04, 2022
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
Personalis to Present at Upcoming Investor Conferences
April 28, 2022
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
May 05, 2022
During Thursday, 351 stocks hit new 52-week lows.
Via
Benzinga
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
April 26, 2022
From
Personalis
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
On Thursday, 236 companies hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.